The Risk of Falls Index for Patients With Neuromuscular Disorders

LMU Klinikum

Status: Completed

Conditions: The Falls Efficacy Scale International; Myasthenia Gravis; Inclusion Body Myositis; The Morse Fall Scale; Facioscapulohumeral Muscular Dystrophies; Myotonic Dystrophy

Treatments: Diagnostic Test: The risk of falls

Study type: Observational

Funder types: Other

Identifiers

NCT05890833

FBIndex_80336

Details and patient eligibility

About

The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device.

The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.

Enrollment: 30 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients between 18- and 65-year-old
• Patients with adequate cognitive and communication function to fill out the scales assessing risk of falling
• The neuromuscular disease needs to be confirmed by genetic report and/or disease deepening neurophysiological examination.

Exclusion criteria

• Patients which are not able to perform motoric functional assessments without assistive gait device.

Trial design

30 participants in 1 patient group

Neuromuscular disorders

Treatment:

Diagnostic Test: The risk of falls